動物用ワクチンの世界市場レポート 2025年

動物用ワクチン市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.5％で194億米ドルに成長します。予測期間の成長は、経済成長、ペット保険の普及率向上、ペット飼育率の上昇、政府イニシアチブの増加、動物の健康に関する意識の高まりに起因すると考えられます。予測期間の主な動向としては、ナノ粒子開発への投資、サブユニットやウイルス様粒子をベースとしたワクチンの増産、パルボウイルス、ジステンパー、アデノウイルスなどのワクチン生産による飼い主の定期的なワクチン接種の義務化、技術進歩への投資の増加、トキソイドワクチンへの投資の増加、mRNAワクチンへの投資増加への注力、戦略的提携やパートナーシップなどが挙げられます。

動物用ワクチン市場は、様々な疾病に罹患する動物の増加により成長を遂げており、これらの疾病を予防・治療するワクチンの需要を生み出しています。英国動植物衛生局（Animal and Plant Health Agency）の報告書によると、イングランドで新たに3289件の結核が検出され、動物における牛結核などの疾病の重要性が浮き彫りになっています。牛の結核のような慢性疾患を含む疾病の蔓延は、予防・治療ソリューションを提供する動物用ワクチンへのニーズの高まりに寄与しています。

動物由来の食品に対する需要の高まりは、今後数年間、動物用ワクチン市場を牽引すると予想されます。動物由来食品には、牛肉、豚肉、鶏肉、魚、牛乳、チーズ、バター、卵、その他幅広い食品や飲食品で一般的に使用されている動物由来成分などが含まれます。動物における疾病予防の必要性は、規制基準や食品安全への懸念とともに、動物用ワクチンの採用拡大を促しています。これらのワクチンは動物の健康を守り、疾病の発生を予防し、食品の品質と安全性について消費者を安心させる。例えば、2023年2月、米国農務省（USDA）は、価格の上昇にもかかわらず、2022年の消費者の鶏肉、牛肉、豚肉の平均消費量は約227ポンドで、2021年の224.9ポンドから増加したと報告しました。その結果、動物由来の食品に対する需要の高まりが、動物用ワクチン市場を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界動物用ワクチンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の動物用ワクチン市場：成長率分析
• 世界の動物用ワクチン市場の実績：規模と成長, 2019-2024
• 世界の動物用ワクチン市場の予測：規模と成長, 2024-2029, 2034F
• 世界動物用ワクチン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の動物用ワクチン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 家畜ワクチン
• ペット用ワクチン
• 世界の動物用ワクチン市場ワクチンの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生弱毒化ワクチン
• 不活化ワクチン
• トキソイドワクチン
• 組み換えワクチン
• その他のワクチンの種類
• 世界の動物用ワクチン市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アナプラズマ症
• 犬パルボウイルス
• 口蹄疫
• ニューカッスル病
• ジステンパー病
• インフルエンザ
• 豚繁殖呼吸器症候群（PRRS）
• 世界の動物用ワクチン市場、家畜ワクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 牛ワクチン
• 家禽ワクチン
• 豚ワクチン
• 小型反芻動物ワクチン（羊および山羊）
• 水産養殖ワクチン
• 世界の動物用ワクチン市場、コンパニオンアニマルワクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 犬のワクチン
• 猫のワクチン
• 馬用ワクチン

第7章 地域別・国別分析

• 世界の動物用ワクチン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の動物用ワクチン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 動物用ワクチン市場：競合情勢
• 動物用ワクチン市場：企業プロファイル
  • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Virbac Group
• HIPRA
• Biogenesis Bago
• Kyoritsu Seiyaku Corporation
• Phibro Animal Health Corporation
• Century Vaccines Limited
• Bayer Animal Health
• Cadila Vaccines Ltd.
• Cargill India Pvt. Ltd.
• China Animal Healthcare Ltd.
• Jurox Pty Ltd
• Nimrod Veterinary Products Ltd.
• Bimeda
• Animalcare
• MSD Animal Health

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 動物用ワクチン市場2029：新たな機会を提供する国
• 動物用ワクチン市場2029：新たな機会を提供するセグメント
• 動物用ワクチン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A veterinary vaccine is a biological preparation designed to stimulate the immune response of an animal, aiming to reduce animal suffering, prevent the transmission of microorganisms within the animal population, and enhance the immune strength of animals for improved health. Additionally, veterinary vaccines play a crucial role in preventing the transmission of diseases from animals to humans.

Various types of veterinary vaccines include live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and other vaccine variants. Inactivated vaccines, distinct from live attenuated vaccines, consist of dead or inactivated viruses and bacteria. The diseases targeted by these vaccines encompass anaplasmosis, canine parvovirus, foot and mouth disease, Newcastle disease, distemper disease, influenza, and porcine reproductive and respiratory syndrome. The application areas for veterinary vaccines extend to both livestock vaccines and companion animal vaccines.

The veterinary vaccines research report is one of a series of new reports from The Business Research Company that provides veterinary vaccines statistics, including veterinary vaccines industry global market size, regional shares, competitors with veterinary vaccines share, detailed veterinary vaccines segments, market trends and opportunities, and any further data you may need to thrive in the veterinary vaccines industry. The veterinary vaccines research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary vaccines market size has grown strongly in recent years. It will grow from $13.56 billion in 2024 to $14.52 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to emerging markets growth, increased pet spending, increased disease prevalence, increased outbreak of poultry diseases, and rising incidence of zoonotic diseases.

The veterinary vaccines market size is expected to see strong growth in the next few years. It will grow to $19.4 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to economic growth, increasing penetration of pet insurance, rise in pet ownership, increase in government initiatives, and growing awareness about animal health. Major trends in the forecast period include investing in the development of nanoparticles, increasing the production of subunit and virus-like particle-based vaccines, production of vaccines like parvovirus, distemper, and adenovirus to provide the mandatory and regular vaccination schedule of pet owners, increasing investment in technological advancements, increasing investment on toxoid vaccines, focus on increasing investment on mRNA vaccines, and strategic collaborations and partnerships.

The veterinary vaccines market is experiencing growth driven by the increasing number of animals afflicted with various diseases, creating a demand for vaccines to prevent and treat these conditions. A report from the Animal and Plant Health Agency highlights 3289 new TB herd incidents detected in England, underscoring the significance of diseases such as bovine tuberculosis in animals. The prevalence of diseases, including chronic ailments such as bovine tuberculosis in cattle, contributes to the heightened need for veterinary vaccines, offering preventive and therapeutic solutions.

The growing demand for animal-derived food products is expected to drive the veterinary vaccine market in the coming years. Animal-derived food products include items such as beef, pork, chicken, fish, milk, cheese, butter, eggs, and other animal-based ingredients commonly used across a wide range of food and beverages. The need for disease prevention in animals, along with regulatory standards and food safety concerns, encourages greater adoption of veterinary vaccines. These vaccines protect animal health, help prevent disease outbreaks, and reassure consumers about the quality and safety of food products. For example, in February 2023, the U.S. Department of Agriculture (USDA) reported that, despite rising prices, consumers on average consumed about 227 pounds of poultry, beef, and pork in 2022-up from 224.9 pounds in 2021. Consequently, the growing demand for animal-derived food products is boosting the veterinary vaccine market.

In the veterinary vaccines market, companies are actively forming strategic partnerships and collaborations to expand into new geographical regions and engage in joint research and development projects. Merck Animal Health, for example, established a four-year strategic alliance with Iowa State University, focusing on innovative solutions in animal health through collaborative efforts in research and development, manufacturing, technology exploration, and business expansion. Such partnerships aim to address animal health challenges globally. MSD Animal Health also entered a strategic partnership with Vinovo, enhancing the vaccination process and improving bird welfare by combining MSD Animal Health's vaccine product line with Vinovo's vaccine delivery system. Additionally, Wageningen bio veterinary research collaborated with Ceva to enhance research on emerging and reemerging diseases for animals.

Key players in the veterinary vaccine market are investing in innovation to maintain a competitive edge. Merck Animal Health, for instance, introduced a new three-in-one swine vaccine named Circumvent CML in June 2023. This vaccine offers protection against Porcine Circovirus Type 2a (PCV-2a), Porcine Circovirus Type 2d (PCV-2d), Mycoplasma hyopneumoniae, and Lawsonia intracellularis. Circumvent CML combines multiple antigens and adjuvant systems in a single bottle, simplifying the vaccination process and reducing stress for animals and caretakers.

The regulatory landscape of the veterinary vaccines market is governed by authorities such as the European Medicines Agency and the US Center for Veterinary Biologics. In Europe, veterinary vaccine companies must adhere to specific technical requirements outlined in Directive 2001/82/EC and European Pharmacopoeia (Ph. Eur.). Safety tests are mandatory for approval, involving in vitro titration for activated vaccines and serological tests for inactivated vaccines. Batch standards for inactivated vaccines necessitate a dose double the standard for each batch, while activated vaccines must undergo testing with a batch ten times the standard dose. These regulatory measures ensure the safety and efficacy of veterinary vaccines.

Major companies operating in the veterinary vaccines market include Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Elanco Animal Health Incorporated, Ceva Sante Animale., Virbac Group, HIPRA, Biogenesis Bago, Kyoritsu Seiyaku Corporation, Phibro Animal Health Corporation, Century Vaccines Limited, Bayer Animal Health, Cadila Vaccines Ltd., Cargill India Pvt. Ltd., China Animal Healthcare Ltd., Jurox Pty Ltd, Nimrod Veterinary Products Ltd., Bimeda, Animalcare, MSD Animal Health, Interfeed, Biotex Plus Ltd., Belfarmacom, IDT Biologika, UCBVET, Lemavet, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, DBK Pharma S.A.E.

North America was the largest region in the veterinary vaccines market in 2024. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in the veterinary vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the veterinary vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The veterinary vaccines market consists of sales of messenger RNA vaccine, viral vector vaccine, and subunit vaccine. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Application: Livestock Vaccines, Companion Animal Vaccines
• 2) By Vaccine Type: Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccine Types
• 3) By Disease Type: Anaplasmosis, Canine Parvovirus, Foot And Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, Porcine Reproductive And Respiratory Syndrome (PRRS)
• Subsegments:
• 1) By Livestock Vaccines: Bovine Vaccines; Poultry Vaccines; Porcine Vaccines; Small Ruminant Vaccines (Sheep and Goats); Aquaculture Vaccines
• 2) By Companion Animal Vaccines: Canine Vaccines; Feline Vaccines; Equine Vaccines
• Companies Mentioned: Zoetis Inc.; Boehringer Ingelheim GmbH; Merck & Co. Inc.; Elanco Animal Health Incorporated; Ceva Sante Animale.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Vaccines Market Characteristics

3. Veterinary Vaccines Market Trends And Strategies

4. Veterinary Vaccines Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Veterinary Vaccines Growth Analysis And Strategic Analysis Framework

• 5.1. Global Veterinary Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Veterinary Vaccines Market Growth Rate Analysis
• 5.4. Global Veterinary Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Veterinary Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Veterinary Vaccines Total Addressable Market (TAM)

6. Veterinary Vaccines Market Segmentation

• 6.1. Global Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Livestock Vaccines
• Companion Animal Vaccines
• 6.2. Global Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Live Attenuated Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Other Vaccine Types
• 6.3. Global Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anaplasmosis
• Canine Parvovirus
• Foot And Mouth Disease
• Newcastle Disease
• Distemper Disease
• Influenza
• Porcine Reproductive And Respiratory Syndrome (PRRS)
• 6.4. Global Veterinary Vaccines Market, Sub-Segmentation Of Livestock Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bovine Vaccines
• Poultry Vaccines
• Porcine Vaccines
• Small Ruminant Vaccines (Sheep and Goats)
• Aquaculture Vaccines
• 6.5. Global Veterinary Vaccines Market, Sub-Segmentation Of Companion Animal Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Canine Vaccines
• Feline Vaccines
• Equine Vaccines

7. Veterinary Vaccines Market Regional And Country Analysis

• 7.1. Global Veterinary Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Veterinary Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Veterinary Vaccines Market

• 8.1. Asia-Pacific Veterinary Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Veterinary Vaccines Market

• 9.1. China Veterinary Vaccines Market Overview
• 9.2. China Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Veterinary Vaccines Market

• 10.1. India Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Veterinary Vaccines Market

• 11.1. Japan Veterinary Vaccines Market Overview
• 11.2. Japan Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Veterinary Vaccines Market

• 12.1. Australia Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Veterinary Vaccines Market

• 13.1. Indonesia Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Veterinary Vaccines Market

• 14.1. South Korea Veterinary Vaccines Market Overview
• 14.2. South Korea Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Veterinary Vaccines Market

• 15.1. Western Europe Veterinary Vaccines Market Overview
• 15.2. Western Europe Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Veterinary Vaccines Market

• 16.1. UK Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Veterinary Vaccines Market

• 17.1. Germany Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Veterinary Vaccines Market

• 18.1. France Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Veterinary Vaccines Market

• 19.1. Italy Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Veterinary Vaccines Market

• 20.1. Spain Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Veterinary Vaccines Market

• 21.1. Eastern Europe Veterinary Vaccines Market Overview
• 21.2. Eastern Europe Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Veterinary Vaccines Market

• 22.1. Russia Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Veterinary Vaccines Market

• 23.1. North America Veterinary Vaccines Market Overview
• 23.2. North America Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Veterinary Vaccines Market

• 24.1. USA Veterinary Vaccines Market Overview
• 24.2. USA Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Veterinary Vaccines Market

• 25.1. Canada Veterinary Vaccines Market Overview
• 25.2. Canada Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Veterinary Vaccines Market

• 26.1. South America Veterinary Vaccines Market Overview
• 26.2. South America Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Veterinary Vaccines Market

• 27.1. Brazil Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Veterinary Vaccines Market

• 28.1. Middle East Veterinary Vaccines Market Overview
• 28.2. Middle East Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Veterinary Vaccines Market

• 29.1. Africa Veterinary Vaccines Market Overview
• 29.2. Africa Veterinary Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Veterinary Vaccines Market Competitive Landscape And Company Profiles

• 30.1. Veterinary Vaccines Market Competitive Landscape
• 30.2. Veterinary Vaccines Market Company Profiles
  • 30.2.1. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis

31. Veterinary Vaccines Market Other Major And Innovative Companies

• 31.1. Virbac Group
• 31.2. HIPRA
• 31.3. Biogenesis Bago
• 31.4. Kyoritsu Seiyaku Corporation
• 31.5. Phibro Animal Health Corporation
• 31.6. Century Vaccines Limited
• 31.7. Bayer Animal Health
• 31.8. Cadila Vaccines Ltd.
• 31.9. Cargill India Pvt. Ltd.
• 31.10. China Animal Healthcare Ltd.
• 31.11. Jurox Pty Ltd
• 31.12. Nimrod Veterinary Products Ltd.
• 31.13. Bimeda
• 31.14. Animalcare
• 31.15. MSD Animal Health

32. Global Veterinary Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Vaccines Market

34. Recent Developments In The Veterinary Vaccines Market

35. Veterinary Vaccines Market High Potential Countries, Segments and Strategies

• 35.1 Veterinary Vaccines Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Veterinary Vaccines Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Veterinary Vaccines Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer